Category: Washington Post

Jiang Yanyong, doctor who exposed China’s SARS coverup, dies at 91

The Chinese state turned against Dr. Jiang when he called for accountability over the 1989 crackdowns in Tiananmen Square.

One of largest fertility clinic mishaps in U.S. settled out of court

Chart Inc., the manufacturer of a tank that failed with 4,000 embryos and eggs inside, has settled with an undisclosed number of people who lost the tissue.

Abortion pill fight may have broader implications for FDA drug approval

A federal judge is being asked in a lawsuit to direct the agency to rescind its approval of mifepristone, one of two drugs used in medication abortions — a move that would be unprecedented.

Texas judge seems open to claim abortion drug was not properly vetted

U.S. Judge Matthew Kacsmaryk says he will rule as soon as possible on FDA approval of mifepristone, one of two drugs used in medical abortions.

An Adderall shortage hasn’t let up. Here’s why.

It puts a spotlight on virtual prescribing and supply chain issues.

What the Texas judge said in delaying notice of abortion-pill hearing

Judge Matthew Kacsmaryk took the unusual step of intentionally delaying public notice of the hearing planned for Wednesday morning in Amarillo, Tex.

EPA proposes rules to limit ‘forever chemicals’ in drinking water

The Biden administration has proposed new rules to reduce exposure to PFOA and PFOS, ubiquitous toxic chemicals from consumer products.

Novo Nordisk becomes latest producer to slash insulin prices

Novo Nordisk said it would cut list prices of several of its insulin products by as much as 75 percent, the latest major producer to reduce prices following public pressure to curb the cost of diabetes treatment.

Biblical city yields unusual case of 3,500-year-old head surgery

The bones of two brothers exhumed from the ancient city of Meggido show that one underwent unsuccessful cranial surgery, possibly to treat an infectious disease

Pfizer seeks another ‘moonshot’ with $43 billion cancer deal

Pfizer said it will buy Seagen, a major push into cancer-fighting drugs as the pharmaceutical giant remakes itself with financial windfall netted from its covid treatments.